Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Frankfurt - Delayed Quote EUR

Algorae Pharmaceuticals Limited (LHI0.F)

Compare
0.0010
0.0000
(0.00%)
At close: March 11 at 8:29:26 AM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
3.1680
--
--
--
--
Gross Profit
3.1680
--
--
--
--
Operating Expense
2,200.7230
2,200.7230
2,130.0510
2,376.7960
2,283.6210
Operating Income
-2,200.7230
-2,200.7230
-2,130.0510
-2,376.7960
-2,283.6210
Net Non Operating Interest Income Expense
125.2000
125.2000
42.0160
3.4050
7.6000
Other Income Expense
-20.0390
-20.0390
-20.1800
0.6190
365.7930
Pretax Income
-2,095.5620
-2,095.5620
-2,107.6580
-2,372.0290
-1,905.4510
Tax Provision
--
--
--
-414.7290
-444.8600
Net Income Common Stockholders
-2,095.5620
-2,095.5620
-2,107.6580
-1,957.3000
-1,460.5910
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Basic Average Shares
1,516,168.3260
1,663,114.2000
1,346,990.3590
886,621.0740
605,495.0910
Diluted Average Shares
1,516,168.3260
1,663,114.2000
1,346,990.3590
886,621.0740
605,495.0910
Net Income from Continuing & Discontinued Operation
-2,095.5620
-2,095.5620
-2,107.6580
-1,957.3000
-1,460.5910
Normalized Income
-2,093.4530
-2,093.4530
-2,107.6580
-1,948.0698
-1,460.5910
Interest Income
125.2000
125.2000
42.0160
3.4050
7.6000
Net Interest Income
125.2000
125.2000
42.0160
3.4050
7.6000
EBIT
-2,200.7230
-2,200.7230
-2,130.0510
-2,376.7960
-2,283.6210
EBITDA
-2,200.7230
-2,200.7230
-2,129.4940
-2,376.0530
-2,278.8440
Reconciled Depreciation
--
--
0.5570
0.7430
4.7770
Net Income from Continuing Operation Net Minority Interest
-2,095.5620
-2,095.5620
-2,107.6580
-1,957.3000
-1,460.5910
Total Unusual Items Excluding Goodwill
-2.1090
-2.1090
--
-12.3070
--
Total Unusual Items
-2.1090
-2.1090
--
-12.3070
--
Normalized EBITDA
-2,198.6140
-2,198.6140
-2,129.4940
-2,363.7460
-2,278.8440
Tax Rate for Calcs
--
--
0.0003
0.0003
0.0002
Tax Effect of Unusual Items
--
--
--
-3.0768
--
6/30/2021 - 9/4/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DNAG DNAPrint Genomics, Inc.
0.0000
-99.00%
 
ARTV Artiva Biotherapeutics, Inc.
5.90
+11.11%
 
CYCCP Cyclacel Pharmaceuticals, Inc.
5.50
-17.42%
 
FOLD Amicus Therapeutics, Inc.
8.88
+2.90%
 
RAPP Rapport Therapeutics, Inc.
8.96
+8.34%
 
XCUR Exicure, Inc.
10.65
-0.47%
 
ALXO ALX Oncology Holdings Inc.
0.9734
+8.93%
 
CAPR Capricor Therapeutics, Inc.
12.58
+1.94%
 
DWTX Dogwood Therapeutics, Inc.
11.13
+31.87%
 
BTAI BioXcel Therapeutics, Inc.
2.4700
-16.84%